This new report provides analysis of Elanco/Bayer’s capabilities, goals and strategies in the global animal health market, including:

- Considering selling animal health division
- Plans to invest in Kiel
- Rising demand for collars
- Focusing on parasiticides and anti-infectives
- Strong position in parasiticides
- Animal health R&D
- Worldwide marketing network
- Emerging markets
- Re-registering existing products
- Present structure
- Diverse businesses
- Challenged by animal disease outbreaks
- Europe's premier research organization
- Animal health R&D
- Crop science segment
- Monsanto acquisition
- Chairman Werner Baumann
- Supervisory board

The report also provides assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and includes five-year forecasts for:

- Major market segments
- Key geographic regions